trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

An overactive parathyroid gland can cause increased bone reabsorption and more fragile bones.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
4 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that an overactive parathyroid gland can cause increased bone reabsorption and more fragile bones?

Yes. An overactive parathyroid gland leads to excess parathyroid hormone secretion, which upregulates osteoclast activity, increases bone resorption, and results in fragile bones or osteoporosis.

Verdict: SUPPORTED · 4 sources for, 0 against · Last checked

The analysis

The retrieved literature consistently confirms that excessive parathyroid hormone (as seen in hyperparathyroidism) stimulates osteoclast-mediated bone resorption, leading to reduced bone mineral density, structural deterioration, and increased bone fragility.

Evidence for · 4
2024
States that excess parathyroid hormone activates osteoclasts to increase bone resorption and decrease bone density.
Get citation
García-Rueda, S., Márquez-Arrico, C., Herrero-Babiloni, A., Silvestre-Rangil, J., & Silvestre, F. (2024). Influence of normocalcemic primary hyperparathyroidism in bone density alterations of the jaws in patients with periodontitis. doi.org. https://doi.org/10.4317/medoral.26958

See more details
More for · 3
2026
Indicates that excess PTH triggers osteoclastic resorption in alveolar bone, culminating in periodontal destruction and bone loss.
Get citation
Kadhum, A. A. H., Bdair, B. W. H., Imeer, A. T. A., Algraittee, S. J. R., & Nassrullah, H. A. (2026). Parathyroid hormone dysregulation and oral microbial dysbiosis in primary hyperparathyroidism; interconnected mechanisms. doi.org. https://doi.org/10.34172/jpd.2026.13318

2026
Notes that parathyroid hormone regulation is a key endocrine factor affecting bone remodeling and secondary osteoporosis.
Get citation
IR, C., R, M., M, M., R, P., M, C., A, M., A, M., F, M., G, M., & A, P. (2026). Endocrine-related osteoporosis: bone quality, clinical phenotype, and targeted management.. doi.org. https://doi.org/10.3389/fendo.2026.1869556

2026
Links elevated parathyroid hormone levels to significant osteoporosis, compression fractures, and osteolytic bone lesions.
Get citation
ME, S., Z, V. G., G, X., A, R., NM, K., & AP, B. (2026). What should be considered to avoid delayed management of parathyroid adenoma: a case report.. doi.org. https://doi.org/10.1097/rc9.0000000000000788

What does the evidence say?

The retrieved literature consistently confirms that excessive parathyroid hormone (as seen in hyperparathyroidism) stimulates osteoclast-mediated bone resorption, leading to reduced bone mineral density, structural deterioration, and increased bone fragility.

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work